Top Organ Preservation Companies

Organ Preservation Market size was valued at USD 263.41 Million in 2024 and is poised to grow from USD 281.32 Million in 2025 to USD 476.19 Million by 2033, growing at a CAGR of 6.8% during the forecast period (2026–2033).

The global organ preservation industry is highly competitive, with several players innovating, merging, and entering alliances with the sole aim of increasing their share of the market. Significant companies include Paragonix Technologies, XVIVO Perfusion AB, Dr. Franz Köhler Chemie GmbH, and OrganOx Limited. These companies are working on the development of technologies concerning preservation and tools such as machine perfusion and new preservation solutions for better functioning of organs. It continues to be a very competitive sector due to technology and the increasing need for organ transplantation across the world. 'Xvivo perfusion ab ', 'Dr. Franz köhler chemie gmbh ', 'Transmedics, inc. ', 'Organox limited ', '21st century medicine ', 'Shanghai genext medical technology co., ltd. ', 'Bridge to life limited ', 'Waters medical systems llc ', 'Preservation solutions, inc. ', 'Carnamedica ', 'Transplant biomedicals ', 'Institut georges lopez ', 'Global transplant solutions ', 'Avionord ', 'Organ preservation solutions ltd. ', 'Ebers ', 'S.a.l.f. ', 'Biochefa ', 'Vascular perfusion solutions, inc. ', 'Tx innovations'

The increasing prevalence of chronic diseases, such as liver and kidney failure, is driving global demand for organ transplants. Increased number of transplant activities raises the demand for efficient organ preservation methods, owing to the fact that the medical anthropology community seeks to maintain the quality of organs and enhance the results of multiple organ operations. 

The infusion of machine perfusion technology is changing organ storage practices as it enhances the supply of oxygen and nutrients during storage. These methods enhance organ preservation and post-transplant outcomes which in turn encourages development of sophisticated preservation technologies for profitable usage considering the high demand of transplant surgery nowadays.

The global organ preservation market is primarily centered within North America, primarily due to the presence of advanced healthcare facilities and infrastructures, a high rate of organ transplant, and sufficient investment for research and development purposes. The region is characterized by the presence of well-established well, government support, and advanced preservation techniques like machine perfusion. Moreover, the presence of leading players in the market plus better understanding of organ donation also enhances the growth of the organ preservation market. Further, the age structure in the region as well as the growing number of chronic diseases increases the need for organ transplant which maintains the region's parameter of leadership. There is ongoing innovation, favorable regulations and strategic partnerships which keep North America at the top of the global organ preservation market share.